Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Medicated Skin Care in

Dermatologicals in the US

22 pages, Nov 2017

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Nappy (diaper) rash treatments suffering from consumers opting for more natural solutions

Dermatologicals comprises a wide range of categories which are growing only slowly, along with two others – medicated shampoos and nappy (diaper) rash treatments – which are in decline, albeit not heavily. With regard to the latter two, it is thought that sales are being adversely affected by consumers’ increasing interest in alternative solutions such as home remedies.

Emergence of “super lice” affecting most US states

Recent studies in the US have shown that the vast majority of lice have become resistant to current OTC treatments, with so-called “super lice” epidemics having spread throughout the US.

COMPETITIVE LANDSCAPE

Brand manufacturers face significant competition from private label options

McNeil Consumer Healthcare remained the leading player in dermatologicals in 2017 thanks to brands such as Neosporin in topical germicidal/antiseptics and Desitin in nappy (diaper) rash treatments. However, private label accounted for a third of dermatological value sales, having slowly gained ground over the review period, led by Walgreen and Wal-Mart.

Well-established brands

Significant brands in dermatologicals in 2017 included the cold sore treatment Abreva from GSK Consumer Healthcare, which claims to “knock out” cold sores in two and a half days and comes in two different presentations, and the vaginal antifungal Monistat from Prestige Brands Holdings. With its three variants – Monistat 1, Monistat 3 and Monistat 7 – these products treat yeast infections in one, three or seven days, together accounting for nearly half of overall vaginal antifungal value sales.

but dermatologicals still fragmented overall

Overall, dermatologicals is highly fragmented in the US, comprising several categories and multiple players. This fragmentation is expected to persist in the coming years, with new entrants facing strong competition unless they can offer significant innovation in terms of product delivery or results.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Medicated Skin Care Market Sample Report Medicated Skin Care Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in USA with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in USA, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in USA market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Medicated Skin Care in USA?
What are the major brands in USA?
What are the most popular formats for acne treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Dermatologicals in the US - Category analysis

HEADLINES

PROSPECTS

Nappy (diaper) rash treatments suffering from consumers opting for more natural solutions

Emergence of “super lice” affecting most US states

COMPETITIVE LANDSCAPE

Brand manufacturers face significant competition from private label options

Well-established brands

but dermatologicals still fragmented overall

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2012-2017
Table 2 Sales of Dermatologicals by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Dermatologicals: % Value 2013-2017
Table 4 LBN Brand Shares of Dermatologicals: % Value 2014-2017
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2014-2017
Table 6 Forecast Sales of Dermatologicals by Category: Value 2017-2022
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022

Consumer Health in the US - Industry Overview

EXECUTIVE SUMMARY

Consumer health products remain popular in the US as lifestyles and demographics dictate the success of various categories

Changing lifestyles provide a roadmap for success in consumer health

Competition is fierce in a fragmented consumer health market

The power of the internet derives from convenience, choice and customisation

The health conditions which accompany ageing are central to future demand

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 9 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2012-2017
Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

Summary 1 OTC: Switches 2016-2017

SOURCES

Summary 2 Research Sources

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

Dermatologicals in the US

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Nappy (diaper) rash treatments suffering from consumers opting for more natural solutions

Emergence of “super lice” affecting most US states

COMPETITIVE LANDSCAPE

Brand manufacturers face significant competition from private label options

Well-established brands

but dermatologicals still fragmented overall

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Dermatologicals in the US - Category analysis

HEADLINES

PROSPECTS

Nappy (diaper) rash treatments suffering from consumers opting for more natural solutions

Emergence of “super lice” affecting most US states

COMPETITIVE LANDSCAPE

Brand manufacturers face significant competition from private label options

Well-established brands

but dermatologicals still fragmented overall

CATEGORY DATA

Consumer Health in the US - Industry Overview

EXECUTIVE SUMMARY

Consumer health products remain popular in the US as lifestyles and demographics dictate the success of various categories

Changing lifestyles provide a roadmap for success in consumer health

Competition is fierce in a fragmented consumer health market

The power of the internet derives from convenience, choice and customisation

The health conditions which accompany ageing are central to future demand

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports